Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Prepaid Assets (2016 - 2025)

Arcadia Biosciences filings provide 12 years of Prepaid Assets readings, the most recent being $156000.0 for Q4 2025.

  • On a quarterly basis, Prepaid Assets fell 83.24% to $156000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $156000.0, a 83.24% decrease, with the full-year FY2025 number at $156000.0, down 83.24% from a year prior.
  • Prepaid Assets hit $156000.0 in Q4 2025 for Arcadia Biosciences, down from $214000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $1.9 million in Q2 2021 to a low of $156000.0 in Q4 2025.
  • Median Prepaid Assets over the past 5 years was $801000.0 (2022), compared with a mean of $824100.0.
  • Biggest five-year swings in Prepaid Assets: surged 42.91% in 2021 and later crashed 83.24% in 2025.
  • Arcadia Biosciences' Prepaid Assets stood at $900000.0 in 2021, then decreased by 11.67% to $795000.0 in 2022, then grew by 1.51% to $807000.0 in 2023, then grew by 15.37% to $931000.0 in 2024, then crashed by 83.24% to $156000.0 in 2025.
  • The last three reported values for Prepaid Assets were $156000.0 (Q4 2025), $214000.0 (Q3 2025), and $383000.0 (Q2 2025) per Business Quant data.